Bradley V. Vaughn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bradley V. Vaughn has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Katelyn Bricker
Division of Sleep Medicine, Chapel Hill, USA
2 shared publications A.D. Baugh
Department of Surgery, Michigan State University, United States
1 shared publication- Amelia F. Drake
University of North Carolina School of Medicine, Chapel Hill, NC
1 shared publication B. Chapman
Department of Neurology, The Ohio State University, United States
1 shared publicationDavid M Umbach
Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA
1 shared publicationDeryck S C Yeung
Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA
1 shared publication
Latest Publications
- 14 November 2026
- Published by Wiley in Muscle & Nerve
Sleep Related Breathing Disorders in Patients With MuSK Myasthenia Gravis, Compared to MuSK Negative Myasthenia Gravis
Introduction: Autoimmune Myasthenia Gravis (MG) is associated with obstructive sleep apnea. Muscle‐specific kinase antibody positive MG (MuSK‐ab+ gMG) patients often have more bulbar weakness than MuSK antibody negative (MuSK‐ab‐) patients, but data comparing sleep‐related breathing disorders is scarce. Methods: Utilizing the University of North Carolina Myasthenia Gravis Registry, 30 MuSK‐ab+ generalized MG (gMG) patients (26 female, 4 male) were matched with 30 MuSK‐ab− gMG patients for age, sex, and Myasthenia Gravis Foundation of America (MGFA) clinical class. Additionally, 30 MuSK‐ab− ocular MG patients were matched for age and sex. Features of sleep‐related symptoms, sleep diagnosis, polysomnogram findings, need for positive airway pressure (PAP) and chronic nocturnal supplemental oxygen were analyzed. Statistical significance was determined using Chi‐square test with 95% confidence intervals and Student T test ( p < 0.05). Results: MuSK‐ab+ MG patients had a higher prevalence of sleep related breathing disorders than the two comparative groups (Odds Ratio [Confidence Interval] 4.97 [1.39–17.82], 3.82 [1.15–12.71], respectively) and for obstructive sleep apnea in MuSK‐ab+ gMG vs. MuSK‐ab− gMG (4.33 [1.20–15.61]). MuSK‐ab+ patients had higher rates of sleep related hypoventilation than MuSK‐ab− groups (8.8 [1.01–76.96], 19.46 [2.18–2574]) and requirement for bilevel PAP and nocturnal supplemental oxygen (Odds ratio for both groups, 23.04 [2.63–3037], 23.0 [2.63–3037]). Discussion: Our cohort suggests MuSK‐ab+ patients are more likely to have sleep‐related breathing disorders independent of MGFA class, age, and sex. Given the long‐term health risks of sleep‐related breathing disorders, we suggest clinicians perform routine sleep screening with a low threshold for in‐laboratory polysomnography.
- 14 November 2026
- Published by Wiley in Muscle & Nerve
Sleep Related Breathing Disorders in Patients With MuSK Myasthenia Gravis, Compared to MuSK Negative Myasthenia Gravis
Introduction: Autoimmune Myasthenia Gravis (MG) is associated with obstructive sleep apnea. Muscle‐specific kinase antibody positive MG (MuSK‐ab+ gMG) patients often have more bulbar weakness than MuSK antibody negative (MuSK‐ab‐) patients, but data comparing sleep‐related breathing disorders is scarce. Methods: Utilizing the University of North Carolina Myasthenia Gravis Registry, 30 MuSK‐ab+ generalized MG (gMG) patients (26 female, 4 male) were matched with 30 MuSK‐ab− gMG patients for age, sex, and Myasthenia Gravis Foundation of America (MGFA) clinical class. Additionally, 30 MuSK‐ab− ocular MG patients were matched for age and sex. Features of sleep‐related symptoms, sleep diagnosis, polysomnogram findings, need for positive airway pressure (PAP) and chronic nocturnal supplemental oxygen were analyzed. Statistical significance was determined using Chi‐square test with 95% confidence intervals and Student T test ( p < 0.05). Results: MuSK‐ab+ MG patients had a higher prevalence of sleep related breathing disorders than the two comparative groups (Odds Ratio [Confidence Interval] 4.97 [1.39–17.82], 3.82 [1.15–12.71], respectively) and for obstructive sleep apnea in MuSK‐ab+ gMG vs. MuSK‐ab− gMG (4.33 [1.20–15.61]). MuSK‐ab+ patients had higher rates of sleep related hypoventilation than MuSK‐ab− groups (8.8 [1.01–76.96], 19.46 [2.18–2574]) and requirement for bilevel PAP and nocturnal supplemental oxygen (Odds ratio for both groups, 23.04 [2.63–3037], 23.0 [2.63–3037]). Discussion: Our cohort suggests MuSK‐ab+ patients are more likely to have sleep‐related breathing disorders independent of MGFA class, age, and sex. Given the long‐term health risks of sleep‐related breathing disorders, we suggest clinicians perform routine sleep screening with a low threshold for in‐laboratory polysomnography.
- Open Access
- 31 December 2024
- Published by Korean Society of Sleep Medicine in Sleep Medicine Research
- Vol. 15 (4) , 228-236
Review of Sleep Disorders and Therapeutic Approaches in Patients With Autism Spectrum Disorder and Rett Syndrome
Sleep complaints are frequent in children with autism spectrum disorder and Rett Syndrome and sleep itself may influence further neurodevelopment in these disorders. This comprehensive review attempts to explore the connection between sleep disorders and brain development in children facing autism spectrum disorder and Rett Syndrome. We will evaluate the underlying neurobiological mechanisms and potential interventions.
- 31 December 2024
- Published by Korean Society of Sleep Medicine in Sleep Medicine Research
- Vol. 15 (4) , 228-236
Open AccessReview of Sleep Disorders and Therapeutic Approaches in Patients With Autism Spectrum Disorder and Rett Syndrome
Sleep complaints are frequent in children with autism spectrum disorder and Rett Syndrome and sleep itself may influence further neurodevelopment in these disorders. This comprehensive review attempts to explore the connection between sleep disorders and brain development in children facing autism spectrum disorder and Rett Syndrome. We will evaluate the underlying neurobiological mechanisms and potential interventions.
- Open Access
- 1 May 2023
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 46 (Supplement) , A395
0897 Sleep Architecture and Epileptiform Discharges in Rett Syndrome
Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder affecting females and is linked to mutations in the methyl-CpG-binding protein 2 (MeCP2) gene. Sleep issues and frequent epileptiform discharges are common in RTT. Typical comorbidities in RTT include poor growth, feeding difficulties, hyperventilation and breath-holding, seizures, scoliosis, and disrupted sleep. Although polysomnographic studies indicate sleep disruption in patients with RTT, few evaluate if the epileptiform activity is associated with significantly greater changes in sleep. We analyzed if epileptiform discharges were associated with greater sleep changes than those seen without epileptiform discharges. This retrospective case control of 10 RTT subjects (mean age, 11.19 years; ranged from 1 to 33 years) underwent standard in-lab polysomnography (PSG) recording. Subjects were compared to 10 age and gender matched controls with an AHI < 5 and no chronic medical problems. Rett children were divided into those with epileptiform discharges and those without. The two groups were compared using binomial cutoffs for each sleep parameter, and significance was determined by Fisher’s Exact Test. All studies were scored using the AASM criteria. Comparing our cohort of RTT patients to control subjects, the RTT patients have higher N3% of sleep, decreased N2%, and shorter sleep onset latency. 4 of the 10 PSGs are notable for frequent interictal epileptiform discharges. However, comparing those RTT patients with epileptiform discharges to those without, only REM latency trending shorter in those with epileptiform discharges (p= 0.057). No other significant differences were seen sleep staging, latency, total sleep time, efficiency, periodic limb movements nor respiratory parameters. Our cohort did not find major differences in sleep features between those RTT patients with epileptiform discharges compared to those without. This may be related to a lack of influence of epileptiform discharges on these parameters or related to our small sample size. Although our cohort did not show major significant differences between those with epileptiform discharges, further study is required to delineate a more subtle relationship of these discharges to sleep.
- 1 May 2023
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 46 (Supplement) , A395
Open Access0897 Sleep Architecture and Epileptiform Discharges in Rett Syndrome
Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder affecting females and is linked to mutations in the methyl-CpG-binding protein 2 (MeCP2) gene. Sleep issues and frequent epileptiform discharges are common in RTT. Typical comorbidities in RTT include poor growth, feeding difficulties, hyperventilation and breath-holding, seizures, scoliosis, and disrupted sleep. Although polysomnographic studies indicate sleep disruption in patients with RTT, few evaluate if the epileptiform activity is associated with significantly greater changes in sleep. We analyzed if epileptiform discharges were associated with greater sleep changes than those seen without epileptiform discharges. This retrospective case control of 10 RTT subjects (mean age, 11.19 years; ranged from 1 to 33 years) underwent standard in-lab polysomnography (PSG) recording. Subjects were compared to 10 age and gender matched controls with an AHI < 5 and no chronic medical problems. Rett children were divided into those with epileptiform discharges and those without. The two groups were compared using binomial cutoffs for each sleep parameter, and significance was determined by Fisher’s Exact Test. All studies were scored using the AASM criteria. Comparing our cohort of RTT patients to control subjects, the RTT patients have higher N3% of sleep, decreased N2%, and shorter sleep onset latency. 4 of the 10 PSGs are notable for frequent interictal epileptiform discharges. However, comparing those RTT patients with epileptiform discharges to those without, only REM latency trending shorter in those with epileptiform discharges (p= 0.057). No other significant differences were seen sleep staging, latency, total sleep time, efficiency, periodic limb movements nor respiratory parameters. Our cohort did not find major differences in sleep features between those RTT patients with epileptiform discharges compared to those without. This may be related to a lack of influence of epileptiform discharges on these parameters or related to our small sample size. Although our cohort did not show major significant differences between those with epileptiform discharges, further study is required to delineate a more subtle relationship of these discharges to sleep.
- Open Access
- 18 April 2023
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 10 (1) , e001506
Sleep apnoea and hypoventilation in patients with five major types of muscular dystrophy
Background The characteristics of and relationship between sleep apnoea and hypoventilation in patients with muscular dystrophy (MD) remain to be fully understood. Methods We analysed 104 in-laboratory sleep studies of 73 patients with MD with five common types (DMD—Duchenne, Becker MD, CMD—congenital, LGMD—limb-girdle and DM—myotonic dystrophy). We used generalised estimating equations to examine differences among these types for outcomes. Results Patients in all five types had high risk of sleep apnoea with 53 of the 73 patients (73%) meeting the diagnostic criteria in at least one study. Patients with DM had higher risk of sleep apnoea compared with patients with LGMD (OR=5.15, 95% CI 1.47 to 18.0; p=0.003). Forty-three per cent of patients had hypoventilation with observed prevalence higher in CMD (67%), DMD (48%) and DM (44%). Hypoventilation and sleep apnoea were associated in those patients (unadjusted OR=2.75, 95% CI 1.15 to 6.60; p=0.03), but the association weakened after adjustment (OR=2.32, 95% CI 0.92 to 5.81; p=0.08). In-sleep average heart rate was about 10 beats/min higher in patients with CMD and DMD compared with patients with DM (p=0.0006 and p=0.02, respectively, adjusted for multiple testing). Conclusion Sleep-disordered breathing is common in patients with MD but each type has its unique features. Hypoventilation was only weakly associated with sleep apnoea; thus, high clinical suspicion is needed for diagnosing hypoventilation. Identifying the window when respiratory muscle weakness begins to cause hypoventilation is important for patients with MD; it enables early intervention with non-invasive ventilation—a therapy that should both lengthen the expected life of these patients and improve its quality.Cite Now
- 18 April 2023
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 10 (1) , e001506
Open AccessSleep apnoea and hypoventilation in patients with five major types of muscular dystrophy
Background The characteristics of and relationship between sleep apnoea and hypoventilation in patients with muscular dystrophy (MD) remain to be fully understood. Methods We analysed 104 in-laboratory sleep studies of 73 patients with MD with five common types (DMD—Duchenne, Becker MD, CMD—congenital, LGMD—limb-girdle and DM—myotonic dystrophy). We used generalised estimating equations to examine differences among these types for outcomes. Results Patients in all five types had high risk of sleep apnoea with 53 of the 73 patients (73%) meeting the diagnostic criteria in at least one study. Patients with DM had higher risk of sleep apnoea compared with patients with LGMD (OR=5.15, 95% CI 1.47 to 18.0; p=0.003). Forty-three per cent of patients had hypoventilation with observed prevalence higher in CMD (67%), DMD (48%) and DM (44%). Hypoventilation and sleep apnoea were associated in those patients (unadjusted OR=2.75, 95% CI 1.15 to 6.60; p=0.03), but the association weakened after adjustment (OR=2.32, 95% CI 0.92 to 5.81; p=0.08). In-sleep average heart rate was about 10 beats/min higher in patients with CMD and DMD compared with patients with DM (p=0.0006 and p=0.02, respectively, adjusted for multiple testing). Conclusion Sleep-disordered breathing is common in patients with MD but each type has its unique features. Hypoventilation was only weakly associated with sleep apnoea; thus, high clinical suspicion is needed for diagnosing hypoventilation. Identifying the window when respiratory muscle weakness begins to cause hypoventilation is important for patients with MD; it enables early intervention with non-invasive ventilation—a therapy that should both lengthen the expected life of these patients and improve its quality.Cite Now
- Open Access
- 1 April 2020
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 43 (Supplement) , A341-A342
0897 Sleep Disordered Breathing In Pediatric Patients With Turner Syndrome
Introduction: Turner syndrome (TS) is a common genetic disorder that affects phenotypic females with partial or complete absence of one X chromosome. It typically presents with characteristic facial appearance, neck webbing, lymphedema, linear growth failure, and ovarian insufficiency. TS is also associated with other disorders, though sleep related disorders are not commonly reported. We present a case series of pediatric patients diagnosed with TS and assess their risk for sleep disordered breathing. Methods: This study utilized retrospective chart review of the electronic medical record at the University of North Carolina at Chapel Hill from April 2014 to January 2019. Only pediatric patients under the age of 18 years who had previously undergone polysomnography and carrying the diagnosis of Turner syndrome were included in this study. Polysomnography results were reviewed. Results: Retrospective chart analysis yielded ten (10) patients who qualified for inclusion. The mean age was 8.3 years (age range 1-15 years). Nine (9) patients were found to have sleep disordered breathing ranging from upper airway resistance syndrome to moderate sleep apnea (AHI range 1.2 to 6.2). Six (6) patients were found to have elevated periodic limb movement indices (PLM index range 5.1 to 30). Parasomnias and hypoventilation were not seen. Conclusion: Our case series illustrates that sleep disordered breathing may be more common in TS than previously realized. Eklund et al. found that females with TS had more retrognathic mandibles and maxillas, shorter mandibles, and larger cranial base angles. These findings may indicate elevated risk of sleep apnea. Further studies are needed to define the overall risk of sleep disordered breathing in TS. Support: None.
- 1 April 2020
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 43 (Supplement) , A341-A342
Open Access0897 Sleep Disordered Breathing In Pediatric Patients With Turner Syndrome
Introduction: Turner syndrome (TS) is a common genetic disorder that affects phenotypic females with partial or complete absence of one X chromosome. It typically presents with characteristic facial appearance, neck webbing, lymphedema, linear growth failure, and ovarian insufficiency. TS is also associated with other disorders, though sleep related disorders are not commonly reported. We present a case series of pediatric patients diagnosed with TS and assess their risk for sleep disordered breathing. Methods: This study utilized retrospective chart review of the electronic medical record at the University of North Carolina at Chapel Hill from April 2014 to January 2019. Only pediatric patients under the age of 18 years who had previously undergone polysomnography and carrying the diagnosis of Turner syndrome were included in this study. Polysomnography results were reviewed. Results: Retrospective chart analysis yielded ten (10) patients who qualified for inclusion. The mean age was 8.3 years (age range 1-15 years). Nine (9) patients were found to have sleep disordered breathing ranging from upper airway resistance syndrome to moderate sleep apnea (AHI range 1.2 to 6.2). Six (6) patients were found to have elevated periodic limb movement indices (PLM index range 5.1 to 30). Parasomnias and hypoventilation were not seen. Conclusion: Our case series illustrates that sleep disordered breathing may be more common in TS than previously realized. Eklund et al. found that females with TS had more retrognathic mandibles and maxillas, shorter mandibles, and larger cranial base angles. These findings may indicate elevated risk of sleep apnea. Further studies are needed to define the overall risk of sleep disordered breathing in TS. Support: None.
- 1 March 2015
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 79 (3) , 356-358
Sleep characteristics in Goldenhar Syndrome
- 1 March 2015
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 79 (3) , 356-358
Sleep characteristics in Goldenhar Syndrome